title: [Acute group A beta-hemolytic streptococcus membranous laryngotracheobronchitis in an adult].
abstract: OBJECTIVE
  To describe the first case of a group A beta-hemolytic streptococcus laryngotracheobronchitis as well as the other possible etiologies in a case of acute dyspnea.
  
  
  METHODS
  We report the case of a 46-year-old woman with a doubtful vaccination status who presented clinical features of croup (laryngotracheobronchitis). She developed respiratory distress and required endotracheal intubation.
  
  
  RESULTS
  The endoscopy demonstrated a great deal of crust and pseudomembrane detachment. Bacterial culture grew group A beta-hemolytic streptococcus. Progression was good with antibiotics and corticosteroid treatment.
  
  
  CONCLUSIONS
  Bacterial acute pseudomembranous croup (laryngotracheobronchitis) is rare. We must search for the most frequent diagnoses such as diphtheria and epiglottitis. This is the first case to be reported in the literature.
authors.affiliation: Service d'otorhinolaryngologie, de chirurgie cervicofaciale et de phoniatrie, hôpital Général, 3, rue du Faubourg-Raines, BP 1519, 21033 Dijon cedex, France. becknicolas@orange.fr
authors.forename: N
authors.initials: N
authors.lastname: Beck
authors.forename: M
authors.initials: M
authors.lastname: Folia
authors.forename: S
authors.initials: S
authors.lastname: Mahy
authors.forename: C
authors.initials: C
authors.lastname: Duvillard
authors.forename: C
authors.initials: C
authors.lastname: Chanteret
authors.forename: H
authors.initials: H
authors.lastname: Lecomte
authors.forename: E
authors.initials: E
authors.lastname: Gazzano
authors.forename: L
authors.initials: L
authors.lastname: Piroth
authors.forename: P
authors.initials: P
authors.lastname: Romanet
mesh_terms: D000208:Acute Disease; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001991:Bronchitis / Q000175:diagnosis / Q000188:drug therapy; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D003440:Croup / Q000175:diagnosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007827:Laryngitis / Q000175:diagnosis / Q000188:drug therapy; D007828:Laryngoscopy; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D013290:Streptococcal Infections / Q000188:drug therapy; D013297:Streptococcus pyogenes / Q000302:isolation & purification*; D013997:Time Factors; D014136:Tracheitis / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D002939:Ciprofloxacin; D002443:Ceftriaxone; D000658:Amoxicillin; D008775:Methylprednisolone